Find your path to Michael
221 people in our graph share verified history with Michael β schools, employers, funds. One of them is your warm intro.
About
Mike Krepps joined the Global BioAccess Fund in 2023 as a Venture Partner and also serves as Chief Strategy Officer for AI Proteins. He previously was COO of the immunotherapy biotech OncoPep, led the investment team at the American Cancer Society's VC fund BrightEdge, and worked as an Associate Principal in CRA's Life Sciences Practice. His background also includes co-founding SynActive Biosciences and serving as a Program Manager/Senior Scientist at the US Department of Defense's Biosciences Division. He holds an MS in genetics and a BS in Bacteriology from the University of Wisconsin-Madison and an MBA from the University of Chicago Booth School of Business.
Invests in
Biotech
Experience
- Global BioAccess FundVenture Partnercurrent2023 β presentBoston, Massachusetts, United States
- ProbiusHead of Biosecuritycurrent2025 β present
- AI ProteinsAdvisor2025Boston, Massachusetts, United States
- AI ProteinsChief Strategy Officer2023 β 2025Boston, Massachusetts, United States
- COBRO VENTURES, INCEIR2021 β 2025Boston, Massachusetts, United States
- OncoPep, Inc.Chief Operating Officer2021 β 2023Cambridge, Massachusetts, United States
- Roivant SciencesPrincipal, Investments2021Basel, Switzerland
- American Cancer Society's BrightEdge FundManaging Principal2019 β 2021Atlanta/Boston
- Interius BiotherapeuticBoard Observer2020Philadelphia, Pennsylvania, United States
- Tmunity Therapeutics IncorporatedBoard Observer2020Philadelphia, Pennsylvania, United States
- Navigating CancerBoard Observer2020Seattle, Washington, United States
- Charles River AssociatesAssociate Principal2018 β 2019Greater Boston Area
- Charles River AssociatesSenior Associate2015 β 2017Boston
- SynActive BiosciencesCo-founder2013 β 2017Baltimore, Maryland Area
- United States Department of DefenseProgram Manager2014Edgewood Chemical Biological Center
- United States Department of DefenseSenior Scientist (Genomics/Bioinformatics)2010 β 2014Edgewood Chemical Biological Center
Skills & more
+12 more
Data AnalysisBusiness StrategyBiotechnologyCell BiologyCell CultureLifesciencesPCRGenomicsStart-upsBusiness DevelopmentCommercializationR&DFrom Michael's professional profile.
Colleagues at Global BioAccess Fund
Frequently asked questions
- Who is Michael Krepps?
- Mike Krepps joined the Global BioAccess Fund in 2023 as a Venture Partner and also serves as Chief Strategy Officer for AI Proteins. He previously was COO of the immunotherapy biotech OncoPep, led the investment team at the American Cancer Society's VC fund BrightEdge, and worked as an Associate Principal in CRA's Life Sciences Practice. His background also includes co-founding SynActive Biosciences and serving as a Program Manager/Senior Scientist at the US Department of Defense's Biosciences Division. He holds an MS in genetics and a BS in Bacteriology from the University of Wisconsin-Madison and an MBA from the University of Chicago Booth School of Business.
- Where does Michael Krepps work?
- Michael Krepps is Venture Partner at Global BioAccess Fund.
- What does Michael Krepps invest in?
- Michael Krepps invests in Biotech.
- Where did Michael Krepps go to school?
- Michael Krepps studied at The University of Chicago Booth School of Business (Master of Business Administration (MBA), Finance; General Management; Entrepreneurship); University of Wisconsin-Madison; University of Wisconsin-Madison.
Same school
Also attended The University of Chicago Booth School of Business785
+ 779 more
Also attended University of Wisconsin-Madison455
+ 449 more










































